Discover
MTNB
Matinas BioPharma Holdings, Inc.
1.51
700 x 1.51
100 x 1.63
bid
ask
-
0.39
20.53%
400 @ 04:12 PM
1.50 -0.01 (0.66%)
| Ytd | 157.68% | |
| 1y | 11.03% |
1.50
day range
1.91
1.47
52 week range
21.30
| Open | 1.87 | Prev Close | 1.90 | Low | 1.50 | High | 1.91 | Mkt Cap | 1.48M |
| Vol | 79.78K | Avg Vol | 92.27K | EPS | -17.55 | P/E | N/A | Forward P/E | -0.17 |
| Beta | 1.73 | Short Ratio | 0.19 | Inst. Own | 26.08% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 08-13 | 50-d Avg | 2.54 | 200-d Avg | 7.04 | 1yr Est | 30.00 |
| Income Statement | |||
| Operating Expenses | 1.69M | ||
| Selling, General and Administrative Expense | 1.56M | ||
| Operating Income | -1.69M | ||
| Net Income | -1.33M | ||
| Net Income Common Stock | -1.33M | ||
| Net Income Common Stock (USD) | -1.33M | ||
| Consolidated Income | -1.33M | ||
| Earnings per Basic Share | -3.15 | ||
| Earnings per Basic Share (USD) | -3.15 | ||
| Earnings per Diluted Share | -3.15 | ||
| Earning Before Interest & Taxes (EBIT) | -1.33M | ||
| Earning Before Interest & Taxes (USD) | -1.33M | ||
| Weighted Average Shares | 427.08K | ||
| Weighted Average Shares Diluted | 427.08K | ||
| Balance Sheet | |||
| Cash and Equivalents | 761.00K | ||
| Cash and Equivalents (USD) | 761.00K | ||
| Investments | 50.00K | ||
| Investments Current | 50.00K | ||
| Current Assets | 1.14M | ||
| Property, Plant & Equipment Net | 9.00K | ||
| Total Assets | 3.41M | ||
| Debt Current | 1000 | ||
| Total Debt | 6.00K | ||
| Current Liabilities | 1.35M | ||
| Debt Non-Current | 5.00K | ||
| Total Liabilities | 1.61M | ||
| Accumulated Retained Earnings (Deficit) | -214.03M | ||
| Shareholders Equity | 1.80M | ||
| Shareholders Equity (USD) | 1.80M | ||
| Assets Non-Current | 2.27M | ||
| Total Debt (USD) | 6.00K | ||
| Liabilities Non-Current | 262.00K | ||
| Trade and Non-Trade Payables | 845.00K | ||
| Tax Liabilities | 257.00K | ||
| Cash Flow | |||
| Depreciation, Amortization & Accretion | -74.00K | ||
| Net Cash Flow from Financing | -1000 | ||
| Net Cash Flow / Change in Cash & Cash Equivalents | -1.84M | ||
| Issuance (Repayment) of Debt Securities | -1000 | ||
| Net Cash Flow from Operations | -1.84M | ||
| Share Based Compensation | 104.00K | ||